0001209191-16-109158.txt : 20160317
0001209191-16-109158.hdr.sgml : 20160317
20160317170327
ACCESSION NUMBER: 0001209191-16-109158
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160315
FILED AS OF DATE: 20160317
DATE AS OF CHANGE: 20160317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCMANUS MICHAEL A JR
CENTRAL INDEX KEY: 0001051997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 161513178
MAIL ADDRESS:
STREET 1: 241-02 NORTHERN BLVD
CITY: DOUGLASTON
STATE: NY
ZIP: 11362
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-03-15
0
0001000694
NOVAVAX INC
NVAX
0001051997
MCMANUS MICHAEL A JR
C/O NOVAVAX, INC.
20 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Stock Option (Right to buy)
4.99
2016-03-15
4
A
0
40000
0.00
A
2016-09-15
2026-03-15
Common Stock
40000
40000
D
One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") 2015 Stock Incentive Plan will vest six (6) months from the March 15, 2016 grant date subject to continued service on the Company's Board of Directors through the vesting date.
/s/ John A. Herrmann III, Attorney-in-Fact
2016-03-17